Volta

Diagnostic Accuracy of a SARS-CoV-2 Antigen Test Obtained by Mid-turbinate Nasal Swabs

Unknown authors · 2025
hash_id: 0f6e7b71404cd26db95395c91e45a878e2fb178d458ee640859e69db3549efcc · DOI: 10.7759/cureus.87120

Context In the early months of the COVID-19 pandemic, polymerase chain reaction (PCR) testing for SARS-CoV-2 was difficult to obtain and took several days to return a result. Our health system wished to explore the use of the Quidel Sofia (Quidel Corporation, San Diego, CA) antigen test to diagnose COVID-19 in our primary care clinics, but the test was approved for emergency use authorization by the US Food and Drug Administration (FDA) with only 250 test subjects. In addition, because it was important to avoid aerosol-generating procedures in primary care clinics, it was necessary to test the diagnostic performance of the antigen test using mid-turbinate (MT) swabs rather than the approved nasopharyngeal (NP) swab technique. Objective The aim of this …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (0)

No outbound references recorded.

Cited by (2)

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection secondary
Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An up… secondary